市场调查报告书
商品编码
1114169
膝关节植入物市场规模、份额和趋势分析报告:按程序类型(全膝关节置换、膝关节置换)、按组件类型(固定轴承、移动轴承植入物)、按地区、分部预测,2022-2030Knee Implants Market Size, Share & Trends Analysis Report By Procedure Type (Total Knee Replacement, Revision Knee Replacement), By Component Type (Fixed-Bearing, Mobile-Bearing Implants), By Region, And Segment Forecasts, 2022 - 2030 |
根据 Grandview Research 的一份新报告,到 2030 年,全球膝关节植入物市场预计将达到 174 亿美元。
预计 2022 年至 2030 年的复合年增长率为 5.7%。这种增长是由于老年人口的增加和慢性类风湿性关节炎如骨关节炎、类风湿性关节炎和创伤后关节炎的激增。引起关节炎的主要因素包括衰老、身体损伤、遗传因素、代谢紊乱、感染和免疫系统异常。
预计在预测期内,先进技术和产品的引入将保持行业竞争力和市场增长水平。例如,X3 Advanced Bearing Technology 和 Mako Robotic-Arm Assisted Technology 能够提供患者特定的 3D 模型来规划部分膝关节置换术。同样在 2016 年 3 月,Zimmer Biomet 推出了 Persona 内侧全等轴承,旨在最大限度地提高关节稳定性,实现更自然的膝关节运动。
医疗保健领域投资的增加、老年人口的增长以及对微创手术的需求不断增加是推动关节置换手术采用的主要因素。预计中国和印度等新兴经济体尚未开发的机会将进一步推动市场增长。为对抗 COVID-19,政府主动只允许必要的手术,而大多数膝关节置换术不符合必要手术的定义。而这些限制阻碍了对膝关节植入设备的需求。
例如,NCBI 发表的一项研究发现,2020 年 7 月,关节成形术医院的每日医疗保险总收入下降了 87%,外科医生的收入下降了 85%。因此,COVID-19 爆发的早期阶段对市场产生了负面影响。由于许多国家禁止医疗产品的进出口,医疗产品的供应链也因封锁而面临挑战。新的重大发展,如合作伙伴关係、产品批准、收购和产品发布,预计将在未来几年对市场产生积极影响。例如,2021 年 11 月,美国 OrthAlign, Inc. 推出了 Lantern,这是一种用于进行全膝关节和部分膝关节置换的手术技术。
全膝关节置换手术将在 2021 年以超过 77.0% 的份额创下最高收入,并有望在预测期内保持其地位
美国和德国等新兴国家对该市场做出了巨大贡献。外科技术的进步和新兴经济体不断增长的需求预计将成为推动增长的关键因素
预计移动轴承植入物细分市场将在预测期内呈现最快的增长。与固定轴承装置相比,这可归因于相关优势,例如磨损更少、性能更长以及可旋转几度
预计北美将在 2021 年主导全球市场,并在预测期内保持其主导地位。预计在预测期内,熟练专业人员的可用性以及高昂的程序成本和报销范围将推动对膝关节植入物的需求
预计亚太地区将成为预测期内增长最快的地区。印度和中国等新兴经济体蓬勃发展的医疗旅游业是推动该地区膝关节置换产品需求的关键因素。
The global knee implants market size is anticipated to reach USD 17.4 billion by 2030, according to a new report published by Grand View Research, Inc. It is expected t register a CAGR of 5.7% from 2022 to 2030. This growth is attributed to the growing elderly population and the surging prevalence of chronic rheumatic conditions, such as osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis. Primary factors that lead to the occurrence of arthritis are aging, physical injuries, genetic inheritance factors, abnormal metabolism, infections, and immune system abnormalities.
The introduction of advanced technologies and products is anticipated to keep the industry rivalry and market growth at par over the forecast period. For example, X3 Advanced Bearing Technology and Mako Robotic-Arm Assisted Technology have the capabilities of providing a patient-specific 3D model to plan partial knee replacement surgeries. In addition, in March 2016, Zimmer Biomet launched the Persona Medial Congruent Bearing, which is designed to enable more natural motion of the knee by maximizing joint stability.
Increasing investment in the healthcare sector, the growing geriatric population, and the rising demand for minimally invasive surgeries are the major factors driving the adoption of joint replacement procedures. Untapped opportunities in developing economies, such as China and India, are further anticipated to impel market growth. To combat COVID-19, the governments took the initiative of allowing only the necessary surgical procedures and the majority of knee arthroplasty surgery did not meet the definition of essential surgery. Such restrictions then hampered the demand for knee implant devices.
For instance, according to a study published by the NCBI, in July 2020, the total daily Medicare revenue from arthroplasty hospitals decreased by 87% and surgeon revenue by 85%. Thus, the initial phase of the COVID-19 outbreak negatively impacted the market. The medical product supply chain also faced difficulty due to the lockdown, as many countries banned the import and export of medical products. New key developments such as partnerships, product approvals, acquisitions, and product launches are expected to positively impact the market in the coming years. For instance, in November 2021, OrthAlign, Inc., a firm based in the U.S., launched Lantern, which is a surgical technology, used to perform total and partial knee replacements.